NATALIE REID: Open Payments
NPI 1326590068 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 44 payments from 16 companies in 2025. Trend: 2023 $1,020 · 2024 $950 · 2025 $991
Food & beverage: $991
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $208 |
| AstraZeneca Pharmaceuticals LP | 8 | $185 |
| ABBVIE INC. | 8 | $146 |
| Astellas Pharma US Inc | 3 | $81 |
| Globus Medical, Inc. | 1 | $62 |
| Merck Sharp & Dohme LLC | 3 | $59 |
| Abbott Laboratories | 2 | $44 |
| PFIZER INC. | 2 | $35 |
| Exact Sciences Corporation | 1 | $30 |
| Lilly USA, LLC | 1 | $26 |
Products named: QULIPTA, Ozempic, Wegovy, Veozah, AIRSUPRA, Senza, BREZTRI, GARDASIL 9.
Industry payments across MD — which companies pay providers there.
